The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.
No matter how diligent your research, finding truthful information about the risks of COVID vaccines can be tricky, according to investigative journalist Sharyl Attkisson.
During a recent segment of “The Sharyl Attkisson Podcast,” Attkisson said information about the safety of COVID vaccines and other medicines is often “falsely portrayed by propagandists and pharmaceutical interests.”
COVID vaccines are being used on an “emergency basis,” said Attkisson, meaning they weren’t subjected to the same safety trials vaccines normally go through before hitting the market. “That’s why we’re learning things in real time as we go,” she said.
Attkisson said the fact that some scientists are calling for an immediate halt to the use of COVID vaccines, at least until new safety measures are put in place, is evidence of mounting concerns about the safety of the vaccines.
Attkisson cited a paper by 57 scientists from 17 countries warning of the potential risks of vaccinating the world with shots that lack adequate safety testing. The authors of the paper, published in Authorea, demanded answers from international health agencies, regulatory authorities, governments and vaccine developers.
The authors wrote:
“Since the start of the COVID-19 outbreak, the race for testing new platforms designed to confer immunity against SARS-CoV-2, has been rampant and unprecedented, leading to conditional emergency authorization of various vaccines. Despite progress on early multidrug therapy for COVID-19 patients, the current mandate is to immunize the world population as quickly as possible. The lack of thorough testing in animals prior to clinical trials, and authorization based on safety data generated during trials that lasted less than 3.5 months, raise questions regarding vaccine safety.
“Given the high rate of occurrence of adverse effects that have been reported to date, as well as the potential for vaccine-driven disease enhancement, Th2-immunopathology, autoimmunity and immune evasion, there is a need for a better understanding of the benefits and risks of mass vaccination, particularly in groups excluded from clinical trials.”